Integrated Investment Consultants LLC Grows Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Integrated Investment Consultants LLC increased its position in UnitedHealth Group by 64.7% in Q1, owning 2,644 shares valued at approximately $1.39 million.
• The company recently increased its quarterly dividend to $2.21, marking a rise from the previous dividend of $2.10, representing an annual yield of 3.15%.
• Analysts have been mixed on UnitedHealth Group, with ratings ranging from a "strong-buy" downgrade by Raymond James to an "overweight" rating from Barclays, reflecting uncertainty in market sentiment.

Integrated Investment Consultants LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 64.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,644 shares of the healthcare conglomerate's stock after acquiring an additional 1,039 shares during the period. Integrated Investment Consultants LLC's holdings in UnitedHealth Group were worth $1,385,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in UnitedHealth Group during the 4th quarter worth about $26,000. Hurley Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $28,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $30,000. IAG Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group during the 1st quarter valued at about $42,000. Finally, Kapitalo Investimentos Ltda acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $41,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Down 5.0%

UNH stock traded down $14.24 during midday trading on Tuesday, hitting $267.88. The stock had a trading volume of 25,033,751 shares, compared to its average volume of 11,481,834. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The business has a 50-day moving average of $300.91 and a two-hundred day moving average of $422.56. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The firm has a market cap of $243.00 billion, a price-to-earnings ratio of 11.21, a price-to-earnings-growth ratio of 1.39 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.16 by ($1.08). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The firm's quarterly revenue was up 12.9% compared to the same quarter last year. During the same period in the prior year, the company earned $6.80 EPS. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 3.30%. The ex-dividend date was Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is 37.02%.

Insider Activity at UnitedHealth Group

In related news, Director Kristen Gil purchased 3,700 shares of UnitedHealth Group stock in a transaction on Thursday, May 15th. The stock was acquired at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the transaction, the director directly owned 3,818 shares in the company, valued at $1,035,327.06. This represents a 3,135.59% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Timothy Patrick Flynn purchased 1,533 shares of UnitedHealth Group stock in a transaction on Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the transaction, the director owned 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought 109,408 shares of company stock valued at $31,607,768 in the last 90 days. 0.28% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on UNH. Wells Fargo & Company reduced their price target on UnitedHealth Group from $351.00 to $306.00 and set an "overweight" rating for the company in a report on Friday. Piper Sandler cut their price objective on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a research note on Tuesday, June 3rd. Raymond James Financial downgraded UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. Wolfe Research cut their price objective on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 20th. Finally, Argus downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and an average price target of $392.29.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.